Therapies
A new-generation probiotic composition for use in the prevention and/or treatment of inflammatory respiratory diseases
Patent inventors: Tomasz Wypych, Magdalena Wolska, Pilar Rodriguez-Viso

A description of the invention will be available after the patent application is published.

Nencki Institute is the sole applicant.

For more information contact Technology Transfer Office.

Application number:
P.455862 (26.05.2026)
Patent status:
pending